Loading...
Chemical structure of SIRT2-IN-9

GC66026

SIRT2-IN-9

Also known as 2-[(5-propyl-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide

SIRT2-IN-9 (compound 12) is a selective inhibitor of SRIT2 with an IC50 value of 1·3 μM· SIRT2-IN-9 inhibits proliferative activity of MCF-7 breast cancer cells· SIRT2-IN-9 can be used for the research of cancer

ChemicalCAS522650-91-5MW438.57FormulaC21H22N6OS2
CAS number
522650-91-5
Molecular weight
438.57
Formula
C21H22N6OS2
Solubility
DMSO ： 4·46 mg/mL (10·17 mM; ultrasonic and warming and heat to 70°C)
InChIKey
CTCRADJXWVDTGQ-UHFFFAOYSA-N
Catalogue number
GC66026
Brand
GLPBIO
Computed properties PubChem CID 2938199 · XLogP 4.1 · TPSA 139 Ų · H-bond donors 1
XLogP
4.1
TPSA
139 Ų
H-bond donors
1
H-bond acceptors
7
Rotatable bonds
6
Heavy atoms
30

SMILES CCCN1C2=CC=CC=C2C3=C1N=C(N=N3)SCC(=O)NC4=NC5=C(S4)CCCC5

Computed descriptors from PubChem (CID 2938199), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.